Papers: 11 Apr 2014 - 18 Apr 2014 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Serum lactate as a novel potential biomarker in multiple sclerosis. Amorini AM, Nociti V, Petzold A, Gasperini C, Quartuccio E, Lazzarino G, Di Pietro V, Belli A, Signoretti S, Vagnozzi R, et al. Biochim Biophys Acta. 2014 Apr 12. Epub 1969 Dec 31. PMID: 24726946. Abstract Editors' Pick Treatment selection and experience in multiple sclerosis: survey of neurologists. Hanson KA, Agashivala N, Wyrwich KW, Raimundo K, Kim E, Brandes DW Patient Prefer Adherence. 2014; 8:415-22. Epub 2014 Apr 03. PMID: 24729689. Abstract Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening. Phillips GA, Wyrwich KW, Guo S, Medori R, Altincatal A, Wagner L, Elkins J Mult Scler. 2014 Apr 16. PMID: 24740371. Abstract Teriflunomide and its mechanism of action in multiple sclerosis. Bar-Or A, Pachner A, Menguy-Vacheron F, Kaplan J, Wiendl H Drugs. 2014 Apr; 74(6):659-74. PMID: 24740824. Abstract PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE. Sathiyanadan K, Coisne C, Enzmann G, Deutsch U, Engelhardt B Eur J Immunol. 2014 Apr 16. PMID: 24740164. Abstract Exome sequencing in single cells from the cerebrospinal fluid in multiple sclerosis. Kemppinen A, Baker A, Liao W, Fiddes B, Jones J, Compston A, Ban M, Sawcer S Mult Scler. 2014 Apr 16. PMID: 24740369. Abstract Central and peripheral demyelination. Mehndiratta M M, Gulati N S J Neurosci Rural Pract. 2014 Jan; 5(1):84-6. PMID: 24741263. Abstract Combined central and peripheral demyelination. Menon B, Bedi S S, Rao U MG J Neurosci Rural Pract. 2014 Jan; 5(1):78-80. PMID: 24741261. Abstract Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis. Gobbi C, Rocca MA, Pagani E, Riccitelli G, Pravatà E, Radaelli M, Martinelli-Boneschi F, Falini A, Copetti M, Comi G, et al. Mult Scler. 2014 Apr 16. PMID: 24740370. Abstract G protein-coupled receptor kinase 2 moderates recruitment of THP-1 cells to the endothelium by limiting histamine-invoked Weibel-Palade body exocytosis. Stevenson NL, Martin-Martin B, Freeman J, Kriston-Vizi J, Ketteler R, Cutler DF J Thromb Haemost. 2014 Feb; 12(2):261-272. PMID: 24735118. Abstract Interferon beta assessment in non-Chinese and Chinese subjects: Pharmacokinetics and pharmacodynamic activity of an endogenous cytokine are not race dependent. Rogge MC, Liu Y, Galluppi GR J Clin Pharmacol. 2014 Apr 15. PMID: 24737408. Abstract Shared environmental effects on multiple sclerosis susceptibility: conflicting evidence from twin studies. Fagnani C, Ricigliano VAG, Buscarinu M C, Nisticò L, Salvetti M, Stazi M A, Ristori G Brain. 2014 Apr 15. PMID: 24736302. Abstract [Multiple sclerosis and occupational exposures: results of an explorative study]. Oddone E, Scaburri A, Modonesi C, Montomoli C, Bergamaschi R, Crosignani P, Imbriani M G Ital Med Lav Ergon. 2013 Jul-Sep; 35(3):133-7. PMID: 24734319. Abstract Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility. Fredj N B, Rizzo R, Bortolotti D, Nefzi F, Chebel S, Rotola A, Frih-Ayed M, Di Luca D, Aouni M J Neuroimmunol. 2014 Mar 30. PMID: 24735502. Abstract TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells. Calabrese R, Valentini E, Ciccarone F, Guastafierro T, Bacalini MG, Ricigliano VAG, Zampieri M, Annibali V, Mechelli R, Franceschi C, et al. Biochim Biophys Acta. 2014 Apr 13. PMID: 24735979. Abstract G protein-coupled receptor kinase 2 moderates recruitment of THP-1 cells to the endothelium by limiting histamine-invoked Weibel-Palade body exocytosis. Stevenson NL, Martin-Martin B, Freeman J, Kriston-Vizi J, Ketteler R, Cutler DF J Thromb Haemost. 2014 Feb; 12(2):261-72. PMID: 24738138. Abstract A Complex Case of Neuro-Behçet's Disease in a Patient Previously Diagnosed with multiple Sclerosis: A Case Report. Shamim A, Budman CL CNS Spectr. 2011 Apr; 16(4):95-8. PMID: 24725371. Abstract Increasing consistency of disease biomarker prediction across datasets. Chikina MD, Sealfon SC PLoS One. 2014; 9(4):e91272. Epub 2014 Apr 16. PMID: 24740471. Abstract Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis. Kaufman M, Pardo G, Rossman H, Sweetser MT, Forrestal F, Duda P J Neurol Sci. 2014 Mar 26. PMID: 24731783. Abstract Erratum. Ann Pharmacother. 2014 May; 48(5):668. PMID: 24733171. Abstract Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system. Williams JL, Patel JR, Daniels BP, Klein RS J Exp Med. 2014 Apr 14. PMID: 24733828. Abstract Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide. Patti F, Messina S, D'Amico E, Lo Fermo S, Zappia M Acta Neurol Scand. 2014 Apr 15. PMID: 24730672. Abstract Laquinimod, an upcoming oral immunomodulatory agent for treatment of multiple sclerosis. Varrin-Doyer M, Zamvil SS, Schulze-Topphoff U Exp Neurol. 2014 Apr 13. PMID: 24731945. Abstract Advances in the treatment of relapsing - Remitting multiple sclerosis. Tanasescu R, Ionete C, Chou I-J, Constantinescu CS Biomed J. 2014 Mar-Apr; 37(2):41-9. PMID: 24732658. Abstract An initial validation of the Italian Mishel Uncertainty Illness Scale (MUIS) for relapsing remitting multiple sclerosis patients. Giammanco M D, Polimeni G, Spadaro L, Gitto L, Buccafusca M, Bramanti P Neurol Sci. 2014 Apr 16. Epub 2014 Apr 16. PMID: 24737348. Abstract The essential role of t cells in multiple sclerosis: A reappraisal. Constantinescu CS, Gran B Biomed J. 2014 Mar-Apr; 37(2):34-40. PMID: 24732657. Abstract Multiple sclerosis. Wei F-C Biomed J. 2014 Mar-Apr; 37(2):33. PMID: 24732656. Abstract Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4. Figueroa M, Guo Y, Tselis A, Pittock SJ, Lennon VA, Lucchinetti CF, Lisak RP JAMA Neurol. 2014 Apr 1; 71(4):495-8. PMID: 24733266. Abstract Diagnostic modalities in multiple sclerosis: Perspectives in children. Chou I-J, Whitehouse WP, Wang H-S, Tanasescu R, Constantinescu CS Biomed J. 2014 Mar-Apr; 37(2):50-9. PMID: 24732659. Abstract Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation. Reick C, Ellrichmann G, Thöne J, Scannevin RH, Saft C, Linker RA, Gold R Exp Neurol. 2014 Apr 13. PMID: 24731948. Abstract Social support and depressive symptoms among caregivers of veterans with multiple sclerosis. Bambara JK, Turner AP, Williams RM, Haselkorn JK Rehabil Psychol. 2014 Apr 14. PMID: 24730574. Abstract Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study. Tsai C-P, Lin F-C, Lee C T-C Mult Scler. 2014 Apr 14. PMID: 24732071. Abstract Serum levels of melatonin and cytokines in multiple sclerosis. Farhadi N, Oryan S, Nabiuni M Biomed J. 2014 Mar-Apr; 37(2):90-2. PMID: 24732664. Abstract R PheWAS: Data Analysis and Plotting Tools for Phenome Wide Association Studies in the R Environment. Carroll RJ, Bastarache L, Denny JC Bioinformatics. 2014 Apr 14. PMID: 24733291. Abstract Analysis of CD4+CD8+ double positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions. Waschbisch A, Sammet L, Schröder S, Lee D-H, Barrantes-Freer A, Stadelmann C, Linker RA Clin Exp Immunol. 2014 Apr 14. PMID: 24730443. Abstract Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients. Yoshimura S, Isobe N, Matsushita T, Masaki K, Sato S, Kawano Y, Ochi H, Kira J-I PLoS One. 2014; 9(4):e95367. Epub 2014 Apr 15. PMID: 24736746. Abstract Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes. Rapôso C, de Luna R L A, Nunes A K S, Thomé R, Peixoto C A Brain Res Bull. 2014 Apr 13. PMID: 24727400. Abstract Clinical and neuroimaging correlation of movement disorders in multiple sclerosis: case series and review of the literature. Potulska-Chromik A, Rudzinska M, Nojszewska M, Podlecka-Piętowska A, Szczudlik A, Zakrzewska-Pniewska B, Gołębiowski M Folia Neuropathol. 2014; 52(1):92-100. PMID: 24729346. Abstract Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading. Cavone L, Peruzzi B, Caporale R, Chiarugi A Br J Pharmacol. 2014 Mar; 171(6):1501-9. PMID: 24730062. Abstract The CSF JCV antibody index for diagnosis of natalizumab-associated PML. Warnke C, von Geldern G, Markwerth P, Dehmel T, Hoepner R, Gold R, Pawlita M, Kümpfel T, Mäurer M, Stangel M, et al. Ann Neurol. 2014 Apr 11. PMID: 24729444. Abstract Personality traits of patients with multiple sclerosis and their relationship with clinical characteristics. Gazioglu S, Cakmak V A, Ozkorumak E, Usta N C, Ates C, Boz C J Nerv Ment Dis. 2014 May; 202(5):408-11. PMID: 24727727. Abstract Structural Biology of the S1P1 Receptor. Hanson MA, Peach R Curr Top Microbiol Immunol. 2014; 378:23-53. PMID: 24728592. Abstract Multiple sclerosis: clinical features and MRI findings in Northern China. Li T, Xiao H, Li S, Du X, Zhou J Eur J Med Res. 2014 Apr 15; 19(1):20. Epub 2014 Apr 15. PMID: 24731721. Abstract Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis. Parkhomenko TA, Doronin VB, Castellazzi M, Padroni M, Pastore M, Buneva VN, Granieri E, Nevinsky GA PLoS One. 2014; 9(4):e93001. Epub 2014 Apr 15. PMID: 24736683. Abstract Disability in multiple sclerosis: When synaptic long-term potentiation fails. Weiss S, Mori F, Rossi S, Centonze D Neurosci Biobehav Rev. 2014 Apr 12. PMID: 24726576. Abstract The trees and the forest: Characterization of complex brain networks with minimum spanning trees. Stam CJ, Tewarie P, Van Dellen E, van Straaten ECW, Hillebrand A, Van Mieghem P Int J Psychophysiol. 2014 Apr 13. PMID: 24726900. Abstract Multiple sclerosis: Benefits of q-space imaging in evaluation of normal-appearing and periplaque white matter. Hori M, Yoshida M, Yokoyama K, Kamagata K, Kumagai F, Fukunaga I, Kamiya K, Suzuki M, Masutani Y, Hamasaki N, et al. Magn Reson Imaging. 2014 Mar 18. PMID: 24726649. Abstract The organization of the sphingosine 1-phosphate signaling system. Rosen H, Germana Sanna M, Gonzalez-Cabrera PJ, Roberts E Curr Top Microbiol Immunol. 2014; 378:1-21. PMID: 24728591. Abstract RORs in Autoimmune Disease. Chang M R, Rosen H, Griffin PR Curr Top Microbiol Immunol. 2014; 378:171-82. PMID: 24728598. Abstract Sphingosine-1 phosphate and central nervous system. Martin R, Sospedra M Curr Top Microbiol Immunol. 2014; 378:149-70. PMID: 24728597. Abstract MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients. Serana F, Imberti L, Amato M P, Comi G, Gasperini C, Ghezzi A, Martinelli V, Provinciali L, Rottoli M R, Sotgiu S, et al. PLoS One. 2014; 9(4):e94794. Epub 2014 Apr 14. PMID: 24733382. Abstract What to expect after natalizumab cessation in a real-life setting. Salhofer-Polanyi S, Baumgartner A, Kraus J, Maida E, Schmied M, Leutmezer F Acta Neurol Scand. 2014 Apr 10. PMID: 24720783. Abstract From precursors to myelinating oligodendrocytes: Contribution of intrinsic and extrinsic factors to white matter plasticity in the adult brain. Boulanger JJ, Messier C Neuroscience. 2014 Apr 8. PMID: 24721734. Abstract Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients. Sorensen P S, Koch-Henriksen N, Petersen T, Ravnborg M, Oturai A, Sellebjerg F J Neurol. 2014 Apr 12. Epub 2014 Apr 12. PMID: 24728334. Abstract Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study. Faiss JH, Dähne D, Baum K, Deppe R, Hoffmann F, Köhler W, Kunkel A, Lux A, Matzke M, Penner IK, et al. BMJ Open. 2014; 4(4):e004409. PMID: 24722197. Abstract [Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa]. Sistiaga A, Castillo-Trivino T, Aliri J, Gaztanaga M, Acha J, Arruti M, Otaegui D, Olascoaga J Rev Neurol. 2014 Apr 16; 58(8):337-44. PMID: 24723176. Abstract The INCAT disability score: A critical analysis of its measurement properties. Breiner A, Barnett C, Bril V Muscle Nerve. 2014 Apr 11. PMID: 24723454. Abstract Relapsing and progressive forms of multiple sclerosis: insights from pathology. Dutta R, Trapp BD Curr Opin Neurol. 2014 Apr 9. PMID: 24722325. Abstract Clinical profile and short-term outcomes of optic neuritis patients in India. Saxena R, Phuljhele S, Menon V, Gadaginamath S, Sinha A, Sharma P Indian J Ophthalmol. 2014 Mar; 62(3):265-7. PMID: 24722269. Abstract Immunological Mechanism of Action and Clinical Profile of Disease-Modifying Treatments in Multiple Sclerosis. Du Pasquier RA, Pinschewer DD, Merkler D CNS Drugs. 2014 Apr 11. PMID: 24723124. Abstract MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment. Filippi M J Neurol. 2014 Apr 11. Epub 2014 Apr 11. PMID: 24723117. Abstract Vitamin D Therapy in Experimental Allergic Encephalomyelitis Could be Limited by Opposing Effects of Sphingosine 1-Phosphate and Gelsolin Dysregulation. Zhu Y, Qin Z, Gao J, Yang M, Qin Y, Shen T, Liu S Mol Neurobiol. 2014 Apr 11. Epub 2014 Apr 11. PMID: 24722820. Abstract A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis. Carrillo-Salinas FJ, Navarrete C, Mecha M, Feliú A, Collado JA, Cantarero I, Bellido ML, Muñoz E, Guaza C PLoS One. 2014; 9(4):e94733. Epub 2014 Apr 11. PMID: 24727978. Abstract Hypercalcaemia and acute kidney injury following administration of vitamin D in granulomatous disease. Tollitt J, Solomon L BMJ Case Rep. 2014; 2014. PMID: 24717583. Abstract Optimization of electron microscopy for human brains with long-term fixation and fixed-frozen sections. Liu X-B, Schumann CM Acta Neuropathol Commun. 2014 Apr 11; 2(1):42. Epub 2014 Apr 11. PMID: 24721148. Abstract Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes. Li R, Xu W, Chen Y, Qiu W, Shu Y, Wu A, Dai Y, Bao J, Lu Z, Hu X PLoS One. 2014; 9(4):e94320. Epub 2014 Apr 10. PMID: 24722370. Abstract Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis. Cocuzza CE, Piazza F, Musumeci R, Oggioni D, Andreoni S, Gardinetti M, Fusco L, Frigo M, Banfi P, Rottoli MR, et al. PLoS One. 2014; 9(4):e94497. Epub 2014 Apr 10. PMID: 24722060. Abstract Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us? Sáenz-Cuesta M, Osorio-Querejeta I, Otaegui D Front Cell Neurosci. 2014; 8:100. Epub 2014 Mar 28. PMID: 24734004. Abstract Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment. Gironi M, Borgiani B, Mariani E, Cursano C, Mendozzi L, Cavarretta R, Saresella M, Clerici M, Comi G, Rovaris M, et al. J Immunol Res. 2014; 2014:961863. Epub 2014 Mar 26. PMID: 24741637. Abstract Oxygen cost of walking in persons with multiple sclerosis: disability matters, but why? Sandroff BM, Klaren RE, Pilutti LA, Motl RW Mult Scler Int. 2014; 2014:162765. Epub 2014 Mar 06. PMID: 24734181. Abstract Fatigue is associated with poor sleep in people with multiple sclerosis and cognitive impairment. Cameron MH, Peterson V, Boudreau EA, Downs A, Lovera J, Kim E, McMillan GP, Turner AP, Haselkorn JK, Bourdette D Mult Scler Int. 2014; 2014:872732. Epub 2014 Mar 05. PMID: 24734182. Abstract Costs of formal and informal home care and quality of life for patients with multiple sclerosis in sweden. Svensson M, Fajutrao L Mult Scler Int. 2014; 2014:529878. Epub 2014 Mar 04. PMID: 24729875. Abstract Does fatigue complaint reflect memory impairment in multiple sclerosis? Jougleux-Vie C, Duhin E, Deken V, Outteryck O, Vermersch P, Zéphir H Mult Scler Int. 2014; 2014:692468. Epub 2014 Mar 02. PMID: 24724029. Abstract Early detection of thrombin activity in neuroinflammatory disease. Davalos D, Baeten KM, Whitney MA, Mullins ES, Friedman B, Olson ES, Ryu J K, Smirnoff DS, Petersen MA, Bedard C, et al. Ann Neurol. 2014 Feb; 75(2):303-8. Epub 2014 Feb 24. PMID: 24740641. Abstract A novel stop mutation in the EDNRB gene in a family with Hirschsprung's disease associated with Multiple Sclerosis. Granström ALöf, Markljung E, Fink K, Nordenskjöld E, Nilsson D, Wester T, Nordenskjöld A J Pediatr Surg. 2014 Apr; 49(4):622-5. Epub 2013 Nov 14. PMID: 24726125. Abstract
Editors' Pick Serum lactate as a novel potential biomarker in multiple sclerosis. Amorini AM, Nociti V, Petzold A, Gasperini C, Quartuccio E, Lazzarino G, Di Pietro V, Belli A, Signoretti S, Vagnozzi R, et al. Biochim Biophys Acta. 2014 Apr 12. Epub 1969 Dec 31. PMID: 24726946. Abstract
Editors' Pick Treatment selection and experience in multiple sclerosis: survey of neurologists. Hanson KA, Agashivala N, Wyrwich KW, Raimundo K, Kim E, Brandes DW Patient Prefer Adherence. 2014; 8:415-22. Epub 2014 Apr 03. PMID: 24729689. Abstract
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening. Phillips GA, Wyrwich KW, Guo S, Medori R, Altincatal A, Wagner L, Elkins J Mult Scler. 2014 Apr 16. PMID: 24740371. Abstract
Teriflunomide and its mechanism of action in multiple sclerosis. Bar-Or A, Pachner A, Menguy-Vacheron F, Kaplan J, Wiendl H Drugs. 2014 Apr; 74(6):659-74. PMID: 24740824. Abstract
PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE. Sathiyanadan K, Coisne C, Enzmann G, Deutsch U, Engelhardt B Eur J Immunol. 2014 Apr 16. PMID: 24740164. Abstract
Exome sequencing in single cells from the cerebrospinal fluid in multiple sclerosis. Kemppinen A, Baker A, Liao W, Fiddes B, Jones J, Compston A, Ban M, Sawcer S Mult Scler. 2014 Apr 16. PMID: 24740369. Abstract
Central and peripheral demyelination. Mehndiratta M M, Gulati N S J Neurosci Rural Pract. 2014 Jan; 5(1):84-6. PMID: 24741263. Abstract
Combined central and peripheral demyelination. Menon B, Bedi S S, Rao U MG J Neurosci Rural Pract. 2014 Jan; 5(1):78-80. PMID: 24741261. Abstract
Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis. Gobbi C, Rocca MA, Pagani E, Riccitelli G, Pravatà E, Radaelli M, Martinelli-Boneschi F, Falini A, Copetti M, Comi G, et al. Mult Scler. 2014 Apr 16. PMID: 24740370. Abstract
G protein-coupled receptor kinase 2 moderates recruitment of THP-1 cells to the endothelium by limiting histamine-invoked Weibel-Palade body exocytosis. Stevenson NL, Martin-Martin B, Freeman J, Kriston-Vizi J, Ketteler R, Cutler DF J Thromb Haemost. 2014 Feb; 12(2):261-272. PMID: 24735118. Abstract
Interferon beta assessment in non-Chinese and Chinese subjects: Pharmacokinetics and pharmacodynamic activity of an endogenous cytokine are not race dependent. Rogge MC, Liu Y, Galluppi GR J Clin Pharmacol. 2014 Apr 15. PMID: 24737408. Abstract
Shared environmental effects on multiple sclerosis susceptibility: conflicting evidence from twin studies. Fagnani C, Ricigliano VAG, Buscarinu M C, Nisticò L, Salvetti M, Stazi M A, Ristori G Brain. 2014 Apr 15. PMID: 24736302. Abstract
[Multiple sclerosis and occupational exposures: results of an explorative study]. Oddone E, Scaburri A, Modonesi C, Montomoli C, Bergamaschi R, Crosignani P, Imbriani M G Ital Med Lav Ergon. 2013 Jul-Sep; 35(3):133-7. PMID: 24734319. Abstract
Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility. Fredj N B, Rizzo R, Bortolotti D, Nefzi F, Chebel S, Rotola A, Frih-Ayed M, Di Luca D, Aouni M J Neuroimmunol. 2014 Mar 30. PMID: 24735502. Abstract
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells. Calabrese R, Valentini E, Ciccarone F, Guastafierro T, Bacalini MG, Ricigliano VAG, Zampieri M, Annibali V, Mechelli R, Franceschi C, et al. Biochim Biophys Acta. 2014 Apr 13. PMID: 24735979. Abstract
G protein-coupled receptor kinase 2 moderates recruitment of THP-1 cells to the endothelium by limiting histamine-invoked Weibel-Palade body exocytosis. Stevenson NL, Martin-Martin B, Freeman J, Kriston-Vizi J, Ketteler R, Cutler DF J Thromb Haemost. 2014 Feb; 12(2):261-72. PMID: 24738138. Abstract
A Complex Case of Neuro-Behçet's Disease in a Patient Previously Diagnosed with multiple Sclerosis: A Case Report. Shamim A, Budman CL CNS Spectr. 2011 Apr; 16(4):95-8. PMID: 24725371. Abstract
Increasing consistency of disease biomarker prediction across datasets. Chikina MD, Sealfon SC PLoS One. 2014; 9(4):e91272. Epub 2014 Apr 16. PMID: 24740471. Abstract
Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis. Kaufman M, Pardo G, Rossman H, Sweetser MT, Forrestal F, Duda P J Neurol Sci. 2014 Mar 26. PMID: 24731783. Abstract
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system. Williams JL, Patel JR, Daniels BP, Klein RS J Exp Med. 2014 Apr 14. PMID: 24733828. Abstract
Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide. Patti F, Messina S, D'Amico E, Lo Fermo S, Zappia M Acta Neurol Scand. 2014 Apr 15. PMID: 24730672. Abstract
Laquinimod, an upcoming oral immunomodulatory agent for treatment of multiple sclerosis. Varrin-Doyer M, Zamvil SS, Schulze-Topphoff U Exp Neurol. 2014 Apr 13. PMID: 24731945. Abstract
Advances in the treatment of relapsing - Remitting multiple sclerosis. Tanasescu R, Ionete C, Chou I-J, Constantinescu CS Biomed J. 2014 Mar-Apr; 37(2):41-9. PMID: 24732658. Abstract
An initial validation of the Italian Mishel Uncertainty Illness Scale (MUIS) for relapsing remitting multiple sclerosis patients. Giammanco M D, Polimeni G, Spadaro L, Gitto L, Buccafusca M, Bramanti P Neurol Sci. 2014 Apr 16. Epub 2014 Apr 16. PMID: 24737348. Abstract
The essential role of t cells in multiple sclerosis: A reappraisal. Constantinescu CS, Gran B Biomed J. 2014 Mar-Apr; 37(2):34-40. PMID: 24732657. Abstract
Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4. Figueroa M, Guo Y, Tselis A, Pittock SJ, Lennon VA, Lucchinetti CF, Lisak RP JAMA Neurol. 2014 Apr 1; 71(4):495-8. PMID: 24733266. Abstract
Diagnostic modalities in multiple sclerosis: Perspectives in children. Chou I-J, Whitehouse WP, Wang H-S, Tanasescu R, Constantinescu CS Biomed J. 2014 Mar-Apr; 37(2):50-9. PMID: 24732659. Abstract
Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation. Reick C, Ellrichmann G, Thöne J, Scannevin RH, Saft C, Linker RA, Gold R Exp Neurol. 2014 Apr 13. PMID: 24731948. Abstract
Social support and depressive symptoms among caregivers of veterans with multiple sclerosis. Bambara JK, Turner AP, Williams RM, Haselkorn JK Rehabil Psychol. 2014 Apr 14. PMID: 24730574. Abstract
Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study. Tsai C-P, Lin F-C, Lee C T-C Mult Scler. 2014 Apr 14. PMID: 24732071. Abstract
Serum levels of melatonin and cytokines in multiple sclerosis. Farhadi N, Oryan S, Nabiuni M Biomed J. 2014 Mar-Apr; 37(2):90-2. PMID: 24732664. Abstract
R PheWAS: Data Analysis and Plotting Tools for Phenome Wide Association Studies in the R Environment. Carroll RJ, Bastarache L, Denny JC Bioinformatics. 2014 Apr 14. PMID: 24733291. Abstract
Analysis of CD4+CD8+ double positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions. Waschbisch A, Sammet L, Schröder S, Lee D-H, Barrantes-Freer A, Stadelmann C, Linker RA Clin Exp Immunol. 2014 Apr 14. PMID: 24730443. Abstract
Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients. Yoshimura S, Isobe N, Matsushita T, Masaki K, Sato S, Kawano Y, Ochi H, Kira J-I PLoS One. 2014; 9(4):e95367. Epub 2014 Apr 15. PMID: 24736746. Abstract
Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes. Rapôso C, de Luna R L A, Nunes A K S, Thomé R, Peixoto C A Brain Res Bull. 2014 Apr 13. PMID: 24727400. Abstract
Clinical and neuroimaging correlation of movement disorders in multiple sclerosis: case series and review of the literature. Potulska-Chromik A, Rudzinska M, Nojszewska M, Podlecka-Piętowska A, Szczudlik A, Zakrzewska-Pniewska B, Gołębiowski M Folia Neuropathol. 2014; 52(1):92-100. PMID: 24729346. Abstract
Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading. Cavone L, Peruzzi B, Caporale R, Chiarugi A Br J Pharmacol. 2014 Mar; 171(6):1501-9. PMID: 24730062. Abstract
The CSF JCV antibody index for diagnosis of natalizumab-associated PML. Warnke C, von Geldern G, Markwerth P, Dehmel T, Hoepner R, Gold R, Pawlita M, Kümpfel T, Mäurer M, Stangel M, et al. Ann Neurol. 2014 Apr 11. PMID: 24729444. Abstract
Personality traits of patients with multiple sclerosis and their relationship with clinical characteristics. Gazioglu S, Cakmak V A, Ozkorumak E, Usta N C, Ates C, Boz C J Nerv Ment Dis. 2014 May; 202(5):408-11. PMID: 24727727. Abstract
Structural Biology of the S1P1 Receptor. Hanson MA, Peach R Curr Top Microbiol Immunol. 2014; 378:23-53. PMID: 24728592. Abstract
Multiple sclerosis: clinical features and MRI findings in Northern China. Li T, Xiao H, Li S, Du X, Zhou J Eur J Med Res. 2014 Apr 15; 19(1):20. Epub 2014 Apr 15. PMID: 24731721. Abstract
Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis. Parkhomenko TA, Doronin VB, Castellazzi M, Padroni M, Pastore M, Buneva VN, Granieri E, Nevinsky GA PLoS One. 2014; 9(4):e93001. Epub 2014 Apr 15. PMID: 24736683. Abstract
Disability in multiple sclerosis: When synaptic long-term potentiation fails. Weiss S, Mori F, Rossi S, Centonze D Neurosci Biobehav Rev. 2014 Apr 12. PMID: 24726576. Abstract
The trees and the forest: Characterization of complex brain networks with minimum spanning trees. Stam CJ, Tewarie P, Van Dellen E, van Straaten ECW, Hillebrand A, Van Mieghem P Int J Psychophysiol. 2014 Apr 13. PMID: 24726900. Abstract
Multiple sclerosis: Benefits of q-space imaging in evaluation of normal-appearing and periplaque white matter. Hori M, Yoshida M, Yokoyama K, Kamagata K, Kumagai F, Fukunaga I, Kamiya K, Suzuki M, Masutani Y, Hamasaki N, et al. Magn Reson Imaging. 2014 Mar 18. PMID: 24726649. Abstract
The organization of the sphingosine 1-phosphate signaling system. Rosen H, Germana Sanna M, Gonzalez-Cabrera PJ, Roberts E Curr Top Microbiol Immunol. 2014; 378:1-21. PMID: 24728591. Abstract
RORs in Autoimmune Disease. Chang M R, Rosen H, Griffin PR Curr Top Microbiol Immunol. 2014; 378:171-82. PMID: 24728598. Abstract
Sphingosine-1 phosphate and central nervous system. Martin R, Sospedra M Curr Top Microbiol Immunol. 2014; 378:149-70. PMID: 24728597. Abstract
MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients. Serana F, Imberti L, Amato M P, Comi G, Gasperini C, Ghezzi A, Martinelli V, Provinciali L, Rottoli M R, Sotgiu S, et al. PLoS One. 2014; 9(4):e94794. Epub 2014 Apr 14. PMID: 24733382. Abstract
What to expect after natalizumab cessation in a real-life setting. Salhofer-Polanyi S, Baumgartner A, Kraus J, Maida E, Schmied M, Leutmezer F Acta Neurol Scand. 2014 Apr 10. PMID: 24720783. Abstract
From precursors to myelinating oligodendrocytes: Contribution of intrinsic and extrinsic factors to white matter plasticity in the adult brain. Boulanger JJ, Messier C Neuroscience. 2014 Apr 8. PMID: 24721734. Abstract
Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients. Sorensen P S, Koch-Henriksen N, Petersen T, Ravnborg M, Oturai A, Sellebjerg F J Neurol. 2014 Apr 12. Epub 2014 Apr 12. PMID: 24728334. Abstract
Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study. Faiss JH, Dähne D, Baum K, Deppe R, Hoffmann F, Köhler W, Kunkel A, Lux A, Matzke M, Penner IK, et al. BMJ Open. 2014; 4(4):e004409. PMID: 24722197. Abstract
[Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa]. Sistiaga A, Castillo-Trivino T, Aliri J, Gaztanaga M, Acha J, Arruti M, Otaegui D, Olascoaga J Rev Neurol. 2014 Apr 16; 58(8):337-44. PMID: 24723176. Abstract
The INCAT disability score: A critical analysis of its measurement properties. Breiner A, Barnett C, Bril V Muscle Nerve. 2014 Apr 11. PMID: 24723454. Abstract
Relapsing and progressive forms of multiple sclerosis: insights from pathology. Dutta R, Trapp BD Curr Opin Neurol. 2014 Apr 9. PMID: 24722325. Abstract
Clinical profile and short-term outcomes of optic neuritis patients in India. Saxena R, Phuljhele S, Menon V, Gadaginamath S, Sinha A, Sharma P Indian J Ophthalmol. 2014 Mar; 62(3):265-7. PMID: 24722269. Abstract
Immunological Mechanism of Action and Clinical Profile of Disease-Modifying Treatments in Multiple Sclerosis. Du Pasquier RA, Pinschewer DD, Merkler D CNS Drugs. 2014 Apr 11. PMID: 24723124. Abstract
MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment. Filippi M J Neurol. 2014 Apr 11. Epub 2014 Apr 11. PMID: 24723117. Abstract
Vitamin D Therapy in Experimental Allergic Encephalomyelitis Could be Limited by Opposing Effects of Sphingosine 1-Phosphate and Gelsolin Dysregulation. Zhu Y, Qin Z, Gao J, Yang M, Qin Y, Shen T, Liu S Mol Neurobiol. 2014 Apr 11. Epub 2014 Apr 11. PMID: 24722820. Abstract
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis. Carrillo-Salinas FJ, Navarrete C, Mecha M, Feliú A, Collado JA, Cantarero I, Bellido ML, Muñoz E, Guaza C PLoS One. 2014; 9(4):e94733. Epub 2014 Apr 11. PMID: 24727978. Abstract
Hypercalcaemia and acute kidney injury following administration of vitamin D in granulomatous disease. Tollitt J, Solomon L BMJ Case Rep. 2014; 2014. PMID: 24717583. Abstract
Optimization of electron microscopy for human brains with long-term fixation and fixed-frozen sections. Liu X-B, Schumann CM Acta Neuropathol Commun. 2014 Apr 11; 2(1):42. Epub 2014 Apr 11. PMID: 24721148. Abstract
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes. Li R, Xu W, Chen Y, Qiu W, Shu Y, Wu A, Dai Y, Bao J, Lu Z, Hu X PLoS One. 2014; 9(4):e94320. Epub 2014 Apr 10. PMID: 24722370. Abstract
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis. Cocuzza CE, Piazza F, Musumeci R, Oggioni D, Andreoni S, Gardinetti M, Fusco L, Frigo M, Banfi P, Rottoli MR, et al. PLoS One. 2014; 9(4):e94497. Epub 2014 Apr 10. PMID: 24722060. Abstract
Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us? Sáenz-Cuesta M, Osorio-Querejeta I, Otaegui D Front Cell Neurosci. 2014; 8:100. Epub 2014 Mar 28. PMID: 24734004. Abstract
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment. Gironi M, Borgiani B, Mariani E, Cursano C, Mendozzi L, Cavarretta R, Saresella M, Clerici M, Comi G, Rovaris M, et al. J Immunol Res. 2014; 2014:961863. Epub 2014 Mar 26. PMID: 24741637. Abstract
Oxygen cost of walking in persons with multiple sclerosis: disability matters, but why? Sandroff BM, Klaren RE, Pilutti LA, Motl RW Mult Scler Int. 2014; 2014:162765. Epub 2014 Mar 06. PMID: 24734181. Abstract
Fatigue is associated with poor sleep in people with multiple sclerosis and cognitive impairment. Cameron MH, Peterson V, Boudreau EA, Downs A, Lovera J, Kim E, McMillan GP, Turner AP, Haselkorn JK, Bourdette D Mult Scler Int. 2014; 2014:872732. Epub 2014 Mar 05. PMID: 24734182. Abstract
Costs of formal and informal home care and quality of life for patients with multiple sclerosis in sweden. Svensson M, Fajutrao L Mult Scler Int. 2014; 2014:529878. Epub 2014 Mar 04. PMID: 24729875. Abstract
Does fatigue complaint reflect memory impairment in multiple sclerosis? Jougleux-Vie C, Duhin E, Deken V, Outteryck O, Vermersch P, Zéphir H Mult Scler Int. 2014; 2014:692468. Epub 2014 Mar 02. PMID: 24724029. Abstract
Early detection of thrombin activity in neuroinflammatory disease. Davalos D, Baeten KM, Whitney MA, Mullins ES, Friedman B, Olson ES, Ryu J K, Smirnoff DS, Petersen MA, Bedard C, et al. Ann Neurol. 2014 Feb; 75(2):303-8. Epub 2014 Feb 24. PMID: 24740641. Abstract
A novel stop mutation in the EDNRB gene in a family with Hirschsprung's disease associated with Multiple Sclerosis. Granström ALöf, Markljung E, Fink K, Nordenskjöld E, Nilsson D, Wester T, Nordenskjöld A J Pediatr Surg. 2014 Apr; 49(4):622-5. Epub 2013 Nov 14. PMID: 24726125. Abstract